Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
12.96-0.40 (-2.99%)
At close: 04:00PM EST
12.76 -0.20 (-1.54%)
After hours: 07:42PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close13.36
Open13.36
Bid12.57 x 800
Ask13.00 x 1200
Day's Range12.74 - 13.49
52 Week Range7.61 - 19.99
Volume2,152,129
Avg. Volume2,653,432
Market Cap2.416B
Beta (5Y Monthly)1.99
PE Ratio (TTM)N/A
EPS (TTM)-1.07
Earnings DateFeb 21, 2023 - Feb 27, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est17.60
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for BCRX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BioCryst Pharmaceuticals, Inc.
    Daily – Vickers Top Buyers & Sellers for 11/26/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    last yearArgus Research
View more
Advertisement
Advertisement